OVIT Share Price Performance
US$0.0001
-0.00 (-50.00%)
Price US$0.0001
Share PriceUS$0.0001
OncoVista Innovative Therapies, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OVIT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
OncoVista Innovative Therapies, Inc. Key Details
About OVIT
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company’s product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
Recent OVIT News & Updates
No updates
